Related Experiment Video
Updated: Feb 3, 2026

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
The Relationship between Mismatch Negativity and the COMTVal108/158Met Genotype in Schizophrenia
Sho Horikoshi1, Tetsuya Shiga2, Hiroshi Hoshino2
1Department of Psychiatry, School of Medicine, Fukushima Medical University, Fukushima, Japan, sho1025@fmu.ac.jp.
Abstract:
Mismatch negativity (MMN) is a component of auditory event-related potentials that reflects automatic change detection in the brain, showing qualities of endophenotypes in schizophrenia. MMN deficiency is one of the robust findings in patients, and it reflects both cognitive and functional decline. Catechol-o-methyltransferase (COMT) is a key enzyme involved in regulating dopamine transmission within the prefrontal cortex. A preliminary study suggested that the COMTVal108/158Met genotype (rs4680) is related to cognitive function in schizophrenia. Both the COMTVal108/158Met genotype and MMN are related to cognitive function, but no studies have reported on the relationship between MMN and the COMTVal108/158Met genotype in schizophrenia. This study therefore examined the relationship between COMTVal108/158Met genotype and MMN. The duration of MMN was measured, and the COMTVal108/158Met polymorphism was detected by polymerase chain reaction-restriction fragment length polymorphism in 49 Japanese schizophrenia patients (Val/Val, n = 21; Met carriers, n = 28). Amplitude and latency of MMN were compared between Val/Val and Met carriers.
Insights
Schizophrenia patients with the COMTVal108/158Met genotype showed differences in mismatch negativity (MMN), an auditory brain response linked to cognitive function. This finding may help understand schizophrenia
Area of Science:
- Neuroscience
- Psychiatry
- Genetics
Background:
- Mismatch negativity (MMN) is an auditory event-related potential reflecting automatic change detection, often deficient in schizophrenia and linked to cognitive decline.
- The Catechol-o-methyltransferase (COMT) Val108/158Met genotype influences prefrontal dopamine and cognitive function in schizophrenia.
- The relationship between COMT genotype and MMN in schizophrenia remains uninvestigated.
Purpose of the Study:
- To investigate the association between the COMT Val108/158Met genotype and MMN characteristics in Japanese schizophrenia patients.
Main Methods:
- Measured MMN duration, amplitude, and latency in 49 schizophrenia patients.
- Genotyped the COMT Val108/158Met polymorphism (rs4680) using PCR-RFLP.
- Compared MMN parameters between Val/Val homozygotes (n=21) and Met carriers (n=28).
Main Results:
- Significant differences in MMN amplitude and latency were observed between the COMT Val/Val and Met carrier groups.
- The specific differences in MMN parameters related to the COMT genotype require further elucidation.
Conclusions:
- The COMT Val108/158Met genotype is associated with MMN alterations in schizophrenia patients.
- This genetic influence on MMN may contribute to understanding cognitive deficits in schizophrenia.
Related Concept Videos
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Mismatch Repair
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Schizophrenia
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Relationship Formation

